140 related articles for article (PubMed ID: 19374543)
1. Advances in the imaging and detection of cervical intra-epithelial neoplasia.
Soutter WP
Future Oncol; 2009 Apr; 5(3):371-8. PubMed ID: 19374543
[TBL] [Abstract][Full Text] [Related]
2. [Preinvasive lesions in gynaecology - uterine cervix].
Mouková L; Feranec R; Chovanec J
Klin Onkol; 2013; 26 Suppl():S49-51. PubMed ID: 24325165
[TBL] [Abstract][Full Text] [Related]
3. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
4. Primary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese population.
Chan KKL; Liu SS; Wei N; Ngu SF; Chu MMY; Tse KY; Lau LSK; Cheung ANY; Ngan HYS
Int J Cancer; 2020 Aug; 147(4):1152-1162. PubMed ID: 31922265
[TBL] [Abstract][Full Text] [Related]
5. CareHPV cervical cancer screening demonstration in a rural population of north India.
Labani S; Asthana S; Sodhani P; Gupta S; Bhambhani S; Pooja B; Lim J; Jeronimo J
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():75-9. PubMed ID: 24685404
[TBL] [Abstract][Full Text] [Related]
6. The current position and the future perspectives of cervical cancer screening.
Bosgraaf RP; Siebers AG; De Hullu JA; Massuger LF; Bulten J; Bekkers RL; Melchers WJ
Expert Rev Anticancer Ther; 2014 Jan; 14(1):75-92. PubMed ID: 24308681
[TBL] [Abstract][Full Text] [Related]
7. Advances in colposcopy: new technologies to challenge current practice.
Leeson S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():140-5. PubMed ID: 25282538
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of the model used for screening and early diagnosis of cervical cancer in Karelia].
Kovchur PI; Bakhidze EV
Vopr Onkol; 2014; 60(3):298-305. PubMed ID: 25033680
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
[TBL] [Abstract][Full Text] [Related]
10. [Impact of HPV testing on cervical cancer screening].
Li G
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):241-5. PubMed ID: 26080933
[No Abstract] [Full Text] [Related]
11. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing Premalignant Lesions of Uterine Cervix in A ResourceConstraint Setting: A Narrative Review.
Grema BA; Aliyu I; Michael GC; Mafala MB
West Afr J Med; 2019; 36(1):48-53. PubMed ID: 30924116
[TBL] [Abstract][Full Text] [Related]
13. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain J; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER; ; ;
Am J Clin Pathol; 2012 Apr; 137(4):516-42. PubMed ID: 22431528
[TBL] [Abstract][Full Text] [Related]
14. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():112-116. PubMed ID: 30682600
[TBL] [Abstract][Full Text] [Related]
15. Secondary prevention of cervical cancer part 1: screening for cervical cancer and its precursors.
Boisen M; Diedrich JT; Lonky NM; Guido R
Clin Obstet Gynecol; 2014 Jun; 57(2):279-91. PubMed ID: 24785416
[TBL] [Abstract][Full Text] [Related]
16. Using technology to harmonise treatment approaches in colposcopy in the face of a changing environment.
Byrom J; Dunn P; Ferguson G; Leeson S; Redman C; Smith J; Tidy J
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():40-43. PubMed ID: 33075678
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of visual inspection with acetic acid as a feasible screening test for cervical neoplasia.
Hasanzadeh M; Esmaeili H; Tabaee S; Samadi F
J Obstet Gynaecol Res; 2011 Dec; 37(12):1802-6. PubMed ID: 21794002
[TBL] [Abstract][Full Text] [Related]
18. CIN III and cervical SCC with negative oncogenic HPV PCR: A case series.
Sturrock S; Griffiths A; Jobling T
Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):154-157. PubMed ID: 31724153
[TBL] [Abstract][Full Text] [Related]
19. Oncologic science on the move: cervical cancer screening.
Winn RJ
J Natl Compr Canc Netw; 2004 Nov; 2(6):519. PubMed ID: 19780295
[No Abstract] [Full Text] [Related]
20. The Bethesda System, the pathology of preinvasive lesions, and screening technology. The Bethesda System (TBS) of nomenclature for cervical smears.
Henry M
J Natl Cancer Inst Monogr; 1996; (21):13-6. PubMed ID: 9101702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
